Clinical Trial Update: Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

View source ↗

Summary

This completed clinical trial reports long-term treatment outcomes for stage III nasopharyngeal carcinoma patients and evaluates risk grouping based on plasma E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv-related Carcinoma
• Nasopharyngeal Carcinoma

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Nasopharyngeal Carcinoma, EBV Related Carcinoma | Status: COMPLETED